Cat.#: ACPP-1073
| Despition | Dopamine D5 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1209 | CaMKII gamma Blocking Peptide (AC1209) | 250 µg | inquiry |
| ACPP-1544 | Human GAPDH Protein (AC1544) | 5 µg | inquiry |
| ACPP-1628 | Human LIF Protein, GST (AC1628) | 2 µg | inquiry |
| ACPP-1617 | Human PARK2 Protein (AC1617) | 5 µg | inquiry |
| ACPP-1709 | Human GPC4 Protein (AC1709) | 2 µg | inquiry |
| ACPP-1339 | MRAP2 Blocking Peptide (AC1339) | 250 µg | inquiry |
| ACPP-1536 | Human EFNB1 Protein (AC1536) | 5 µg | inquiry |
| ACPP-1014 | Recombinant Human P Cadherin Protein (6×His Tag) (AC1014) | 50 µg | inquiry |
| ACPP-1642 | ENPP2 Blocking Peptide (AC1642) | 250 µg | inquiry |
| ACPP-1602 | Human AKR7A2 Protein (AC1602) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.